SEMAGLUTIDE/L-CARNITINE

Injectable weight loss medications like semaglutide are GLP-1 receptor agonists that aid in weight management by enhancing insulin secretion, suppressing glucagon, and slowing gastric emptying, leading to reduced appetite and calorie intake. Clinical studies have demonstrated that semaglutide can result in an average weight loss of approximately 15%. These treatments are administered via subcutaneous injection, starting with a low dose and gradually increasing over the first few months to a maintenance dose. Common side effects include nausea and abdominal discomfort, which often diminish over time. Some patients find that vitamin B12 supplementation helps alleviate these symptoms.